Dr. Jacobo Mintzer, MD

Claim this profile

South Carolina Institute for Brain Health

Studies Dementia
Studies Alzheimer's Disease
4 reported clinical trials
6 drugs studied

Affiliated Hospitals

Image of trial facility.
Roper St. Francis Hospital
Image of trial facility.
Roper St. Francis Healthcare

Clinical Trials Jacobo Mintzer, MD is currently running

Image of trial facility.

CBD + THC

for Agitation in Dementia

This is a multicenter randomized double-blind placebo-controlled Phase 2 study of an oral combination of tetrahydrocannabinol (THC) and cannabidiol (CBD) compared to placebo over 12 weeks. This study is designed to test the hypothesis that treatment with an oral combination of THC/CBD will reduce agitation hospice care-eligible patients with agitation and dementia as measured by the Cohen Mansfield Agitation Inventory (CMAI) when compared to placebo at 2 weeks. This study will enroll approximately 150 participants of any gender at least 40 years of age who are hospice care-eligible with agitation and dementia (HAD). Participants will be randomized (50:50) to either active study drug (T2:C100) or placebo. The double-blind period of this study is 12 weeks. A 12 week optional open-label extension will be offered to participants who complete the double-blind period.
Recruiting0 awards Phase 215 criteria

More about Jacobo Mintzer, MD

Clinical Trial Related1 year of experience running clinical trials · Led 4 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments Jacobo Mintzer, MD has experience with
  • Cannabidiol (CBD)
  • Tetrahydrocannabinol (THC)
  • Placebo
  • Simufilam
  • APT Webstudy
  • Escitalopram
Breakdown of trials Jacobo Mintzer, MD has run
Dementia
Alzheimer's Disease
Akathisia
Agitation
Mild Cognitive Impairment

Other Doctors you might be interested in

Jessica Broadway, MDRalph H. Johnson VA Health Care System
William C McManigle, MDRalph H. Johnson VA Medical Center

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jacobo Mintzer, MD specialize in?
Jacobo Mintzer, MD focuses on Dementia and Alzheimer's Disease. In particular, much of their work with Dementia has involved treating patients, or patients who are undergoing treatment.
Is Jacobo Mintzer, MD currently recruiting for clinical trials?
Yes, Jacobo Mintzer, MD is currently recruiting for 1 clinical trial in Charleston South Carolina. If you're interested in participating, you should apply.
Are there any treatments that Jacobo Mintzer, MD has studied deeply?
Yes, Jacobo Mintzer, MD has studied treatments such as Cannabidiol (CBD), Tetrahydrocannabinol (THC), Placebo.
What is the best way to schedule an appointment with Jacobo Mintzer, MD?
Apply for one of the trials that Jacobo Mintzer, MD is conducting.
What is the office address of Jacobo Mintzer, MD?
The office of Jacobo Mintzer, MD is located at: South Carolina Institute for Brain Health, Charleston, South Carolina 29403 United States. This is the address for their practice at the South Carolina Institute for Brain Health.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top